X @Bloomberg
Amgen boosted its 2025 guidance after quarterly results beat Wall Street’s estimates on the back of strong sales from older medicines https://t.co/ZKgYw1wi8R ...
Amgen boosted its 2025 guidance after quarterly results beat Wall Street’s estimates on the back of strong sales from older medicines https://t.co/ZKgYw1wi8R ...